Pharmacy

Your Article Summary

See Latest Articles

Ivabradine: the evidence of its therapeutic impact in angina
Core Evidence, 08/17/09

Marquis–Gravel G et al. – Ivabradine is an effective antianginal and antiischemic drug, not inferior to the beta blocker atenolol and the calcium channel antagonist (CCA) amlodipine. It decreases the frequency of angina attacks and increases the time to anginal symptoms during exercise. Because of its exclusive chronotropic effect, ivabradine is not associated with the typical adverse reactions associated with beta blockers or other antianginal drugs. Clinical evidence shows that ivabradine is a very good antiischemic and antianginal agent, being as effective as beta blockade and CCA therapy in controlling myocardial ischemia and symptoms of stable angina. Ongoing studies will determine the potential of ivabradine to improve morbidity and mortality in coronary artery disease and heart failure.

Related Articles

See all related articles

Effect of Antianginal Drugs in Stable Angina on Predicted Mortality Risk after Surviving a Myocardial Infarction: A Preliminary Study (METRO)
American Journal of Cardiovascular Drugs, 10/06/09    Relevance Score: 88%

A prolonged buried fish bone mimicking Ludwig angina
American Journal of Otolaryngology, 11/03/09    Relevance Score: 85%

The profile of circulating metalloproteinases after PCI in patients with acute myocardial infarction or stable angina
Thrombosis Research, 10/20/09    Relevance Score: 85%

Comparison of Prolonged Bivalirudin Infusion Versus Intraprocedural in Preventing Myocardial Damage After Percutaneous Coronary Intervention in Patients With Angina Pectoris
The American Journal of Cardiology, 10/14/09    Relevance Score: 83%

Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: Long-term clinical and functional prognosis
International Journal of Cardiology, 10/07/09    Relevance Score: 82%

Today in Cardiac/Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise
Internal Medicine Journal, 03/19/10

Ranolazine-related dyspnea on exertion
The American Journal of Geriatric Pharmacotherapy, 03/19/10

Meta-Analysis of Dose–Response Characteristics of Hydrochlorothiazide and Chlorthalidone: Effects on Systolic Blood Pressure and Potassium
American Journal of Hypertension, 03/19/10

 See all of Cardiac/Hypertension